Hruy Menghesha, F. Dörr, M. Heldwein, G. Schlachtenberger, T. Wahlers, Khosro Hekmat
{"title":"摘要分析我国","authors":"Hruy Menghesha, F. Dörr, M. Heldwein, G. Schlachtenberger, T. Wahlers, Khosro Hekmat","doi":"10.1515/iss-2022-2007","DOIUrl":null,"url":null,"abstract":"Non-Small Cell Lung Cancer is still one of the leading causes for death worldwide. Therapy-determining staging systems underly necessarily continuous reevaluation. In particular, tumor size, lymph node involvement, and distant metastasis are paramount in defining therapy. Recent studies have shown that Haemangiosis Carcinomatosa (V1) impacts the long-term survival of patients with Non-Small Cell Lung Cancer (NSCLC). The aim of the present study was to emphasize blood-vessel invasion (BVI) as an independent risk factor. We analyzed the effect of V1 on survival in UICC stage I, II and III postoperative NSCLC-patients","PeriodicalId":44186,"journal":{"name":"Innovative Surgical Sciences","volume":"1 1","pages":"288 - 296"},"PeriodicalIF":1.7000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstracts DGT\",\"authors\":\"Hruy Menghesha, F. Dörr, M. Heldwein, G. Schlachtenberger, T. Wahlers, Khosro Hekmat\",\"doi\":\"10.1515/iss-2022-2007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Non-Small Cell Lung Cancer is still one of the leading causes for death worldwide. Therapy-determining staging systems underly necessarily continuous reevaluation. In particular, tumor size, lymph node involvement, and distant metastasis are paramount in defining therapy. Recent studies have shown that Haemangiosis Carcinomatosa (V1) impacts the long-term survival of patients with Non-Small Cell Lung Cancer (NSCLC). The aim of the present study was to emphasize blood-vessel invasion (BVI) as an independent risk factor. We analyzed the effect of V1 on survival in UICC stage I, II and III postoperative NSCLC-patients\",\"PeriodicalId\":44186,\"journal\":{\"name\":\"Innovative Surgical Sciences\",\"volume\":\"1 1\",\"pages\":\"288 - 296\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2022-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovative Surgical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/iss-2022-2007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovative Surgical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/iss-2022-2007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Non-Small Cell Lung Cancer is still one of the leading causes for death worldwide. Therapy-determining staging systems underly necessarily continuous reevaluation. In particular, tumor size, lymph node involvement, and distant metastasis are paramount in defining therapy. Recent studies have shown that Haemangiosis Carcinomatosa (V1) impacts the long-term survival of patients with Non-Small Cell Lung Cancer (NSCLC). The aim of the present study was to emphasize blood-vessel invasion (BVI) as an independent risk factor. We analyzed the effect of V1 on survival in UICC stage I, II and III postoperative NSCLC-patients
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
